Search Results

There are 44266 results for: content related to: Pityriasis rubra pilaris-like reaction induced by imatinib

  1. Human hepatocyte assessment of imatinib drug–drug interactions – complexities in clinical translation

    British Journal of Clinical Pharmacology

    Volume 80, Issue 5, November 2015, Pages: 1097–1108, Jan H. Beumer, Venkateswaran C. Pillai, Robert A. Parise, Susan M. Christner, Brian F. Kiesel, Michelle A. Rudek and Raman Venkataramanan

    Version of Record online : 19 SEP 2015, DOI: 10.1111/bcp.12723

  2. You have free access to this content
    Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates

    British Journal of Pharmacology

    Volume 165, Issue 8, April 2012, Pages: 2787–2798, AM Filppula, J Laitila, PJ Neuvonen and JT Backman

    Version of Record online : 23 MAR 2012, DOI: 10.1111/j.1476-5381.2011.01732.x

  3. Chronic Myelogenous Leukemia

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt008

  4. Adiponectin enhances Imatinib anti-tumour activity in human chronic myeloid leukaemia cells with serum levels associated with Imatinib efficacy in early chronic phase patients

    Cell Proliferation

    Volume 48, Issue 4, August 2015, Pages: 486–496, Guangshan Tan, Lei Shi, Qiang Li and Mingjun Wang

    Version of Record online : 6 JUL 2015, DOI: 10.1111/cpr.12194

  5. You have free access to this content
    Measuring response to BCR-ABL inhibitors in chronic myeloid leukemia


    Volume 118, Issue 2, 15 January 2012, Pages: 300–311, Jerald P. Radich

    Version of Record online : 29 JUN 2011, DOI: 10.1002/cncr.26280

  6. You have free access to this content
    Optimizing therapy for patients with chronic myelogenous leukemia in chronic phase


    Volume 116, Issue 6, 15 March 2010, Pages: 1419–1430, Hagop M. Kantarjian, Jorge Cortes, Paul La Rosée and Andreas Hochhaus

    Version of Record online : 29 JAN 2010, DOI: 10.1002/cncr.24928

  7. Advanced or metastatic gastrointestinal stromal tumors: Systemic treatment options

    Journal of Surgical Oncology

    Volume 104, Issue 8, 15 December 2011, Pages: 888–895, Megan V. Caram and Scott M. Schuetze

    Version of Record online : 8 NOV 2011, DOI: 10.1002/jso.21930

  8. A molecular mechanics model for imatinib and imatinib:kinase binding

    Journal of Computational Chemistry

    Volume 31, Issue 7, May 2010, Pages: 1550–1560, Alexey Aleksandrov and Thomas Simonson

    Version of Record online : 17 DEC 2009, DOI: 10.1002/jcc.21442

  9. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells

    Journal of Cellular Physiology

    Volume 205, Issue 2, November 2005, Pages: 218–227, Faye M. Johnson, Babita Saigal and Nicholas J. Donato

    Version of Record online : 10 MAY 2005, DOI: 10.1002/jcp.20383

  10. Pharmacokinetic Impact of SLCO1A2 Polymorphisms on Imatinib Disposition in Patients With Chronic Myeloid Leukemia

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 1, July 2011, Pages: 157–163, Y Yamakawa, A Hamada, T Shuto, M Yuki, T Uchida, H Kai, T Kawaguchi and H Saito

    Version of Record online : 1 JUN 2011, DOI: 10.1038/clpt.2011.102

  11. Co-encapsulation of anti-BCR-ABL siRNA and imatinib mesylate in transferrin receptor-targeted sterically stabilized liposomes for chronic myeloid leukemia treatment

    Biotechnology and Bioengineering

    Volume 107, Issue 5, 1 December 2010, Pages: 884–893, Liliana S. Mendonça, João N. Moreira, Maria C. Pedroso de Lima and Sérgio Simões

    Version of Record online : 14 JUL 2010, DOI: 10.1002/bit.22858

  12. Enzyme- and Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 12, December 2014, Pages: 3810–3833, Jie Shao, John S. Markowitz, Di Bei and Guohua An

    Version of Record online : 10 OCT 2014, DOI: 10.1002/jps.24113

  13. Imatinib inhibits inactivation of the ATM/ATR signaling pathway and recovery from adriamycin/doxorubicin-induced DNA damage checkpoint arrest

    Cell Biology International

    Volume 39, Issue 8, August 2015, Pages: 923–932, Mariko Morii, Yasunori Fukumoto, Sho Kubota, Noritaka Yamaguchi, Yuji Nakayama and Naoto Yamaguchi

    Version of Record online : 27 APR 2015, DOI: 10.1002/cbin.10460

  14. You have free access to this content
    Controversies in the management of gastrointestinal stromal tumors

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue 3, September 2014, Pages: 216–227, Desmond Yip, John Zalcberg, Stephen Ackland, Andrew P Barbour, Jayesh Desai, Stephen Fox, Dusan Kotasek, Grant McArthur and B Mark Smithers

    Version of Record online : 27 MAR 2014, DOI: 10.1111/ajco.12187

  15. You have free access to this content
    Imatinib Promotes Osteoblast Differentiation by Inhibiting PDGFR Signaling and Inhibits Osteoclastogenesis by Both Direct and Stromal Cell-Dependent Mechanisms

    Journal of Bone and Mineral Research

    Volume 22, Issue 11, November 2007, Pages: 1679–1689, Susannah O'Sullivan, Dorit Naot, Karen Callon, Fran Porteous, Anne Horne, Diana Wattie, Maureen Watson, Jill Cornish, Peter Browett and Andrew Grey

    Version of Record online : 30 JUL 2007, DOI: 10.1359/jbmr.070719

  16. Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate

    Liver International

    Volume 32, Issue 6, July 2012, Pages: 1008–1017, Youngchul Kim, Maria I. Fiel, Efsevia Albanis, Hsin I. Chou, Weijia Zhang, Gregory Khitrov and Scott L. Friedman

    Version of Record online : 16 APR 2012, DOI: 10.1111/j.1478-3231.2012.02806.x

  17. Imatinib mesylate in children and adolescents with cancer

    Pediatric Blood & Cancer

    Volume 55, Issue 1, 15 July 2010, Pages: 18–25, Ronald D. Barr

    Version of Record online : 1 APR 2010, DOI: 10.1002/pbc.22484

  18. Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors

    The Journal of Clinical Pharmacology

    Volume 55, Issue 8, August 2015, Pages: 920–925, Sheima Farag, Arjan J. Verschoor, Jacob W. Bosma, Hans Gelderblom, J. Martijn Kerst, Stefan Sleijfer and Neeltje Steeghs

    Version of Record online : 6 MAY 2015, DOI: 10.1002/jcph.498

  19. You have free access to this content
    Practical management of patients with chronic myeloid leukemia


    Volume 117, Issue 19, 1 October 2011, Pages: 4343–4354, Francisco Cervantes and Michael Mauro

    Version of Record online : 16 MAR 2011, DOI: 10.1002/cncr.26062

  20. You have full text access to this OnlineOpen article
    The tyrosine kinase inhibitor imatinib prevents lung injury and death after intravenous LPS in mice

    Physiological Reports

    Volume 3, Issue 11, November 2015, R. Scott Stephens, Laura Johnston, Laura Servinsky, Bo S. Kim and Mahendra Damarla

    Version of Record online : 30 NOV 2015, DOI: 10.14814/phy2.12589